Covered recipient · General Payments record
POONGOTHAI SUNDARAM
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$16,967.67
- Reported across 259 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,248.78 | 48 |
| Honoraria | $1,200.00 | 1 |
| Long term medical supply or device loan | $897.30 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $1,258.47 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $1,101.97 | 17 |
| Adaptive Biotechnologies Corporation | $149.48 | 1 |
| Daiichi Sankyo Inc. | $77.32 | 3 |
| EISAI INC. | $67.75 | 3 |
| Merck Sharp & Dohme Corporation | $59.97 | 2 |
| SpringWorks Therapeutics, Inc. | $55.76 | 1 |
| Astellas Pharma US Inc | $55.23 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $55.11 | 2 |
| ABBVIE INC. | $44.54 | 2 |
| Amneal Pharmaceuticals LLC | $35.83 | 2 |
| Karyopharm Therapeutics Inc. | $32.58 | 1 |
| Gilead Sciences, Inc. | $31.77 | 2 |
| Janssen Biotech, Inc. | $31.49 | 1 |
| BeiGene USA, Inc. | $29.11 | 1 |
| GlaxoSmithKline, LLC. | $27.37 | 1 |
| ARRAY BIOPHARMA INC | $24.73 | 1 |
| Incyte Corporation | $24.43 | 1 |
| Regeneron Healthcare Solutions, Inc. | $22.04 | 1 |
| Lilly USA, LLC | $21.97 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $20.78 | 1 |
| SOBI, INC | $18.62 | 1 |
| TAIHO ONCOLOGY, INC. | $17.96 | 1 |
| SERVIER PHARMACEUTICALS LLC | $17.79 | 1 |
| Celgene Corporation | $17.48 | 1 |
| Genentech USA, Inc. | $16.40 | 1 |
| EMD Serono, Inc. | $16.25 | 1 |
| E.R. Squibb & Sons, L.L.C. | $13.88 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (58)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.